Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.49B
Enterprise Value6.15B
P/E Ratio32.36
PEG Ratio-0.55
Price/Sales Ratio0.62
Price/Book Ratio0.96
Enterprise/Revenue0.99
Enterprise/EBITDA12.75

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.02
Operating Margin0.03
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.03

Income Statement

Revenue4.19B
Revenue/Share16.35
Gross Profit629.45M
EBITDA619.56M
Net Income200.3M
Diluted EPS0.66

Balance Sheet

Total Cash1.64B
Total Cash/Share5.44
Total Debt3.36B
Total Debt/Equity1.05
Current Ratio1.35
Book Value Per Share10.65

Price History

52-Week Change-42.42
52-Week High19.44
52-Week Low9.73
Moving Average 50 Days11.22
Moving Average 200 Days13.42

Statistics

Average Volume7.96M
Shares Outstanding300.93M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.5
Trailing Annual Dividend Yield4.89
Payout Ratio1.42
Last Split Factor13:10
Last Split DateMay 28, 2024
AD